David Domzalski - 30 Jun 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Issuer symbol
VYNE
Transactions as of
30 Jun 2022
Net transactions value
-$4,156
Form type
4
Filing time
05 Jul 2022, 17:00:30 UTC
Previous filing
02 Jun 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $4,156 -10,683 -1% $0.3890 1,050,953 30 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.